Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anglo-Scandinavian Cardiac Outcomes Trial Post-Trial Follow-Up (ASCOT-PTF)
2010-023875-24Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin, atenolol, perindopril and amlodipine in hypertension (HTN), cardiac morbidity and hypercholesterolemia (4 arms), sponsored by Imperial College London. Primary endpoint: Primary composite cardiovascular endpoint. Started Jan 2011; status: completed.
02
Drugs
atorvastatinatenololperindoprilamlodipine
03
Conditions
hypertension (HTN)cardiac morbidityhypercholesterolemia
Beyond the preview
Go deeper on 2010-023875-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023875-24.